Cargando…

Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation

OBJECTIVES: The aim of this study was to evaluate the association between vasoactive–inotropic score (VIS), calculated in the 24 h after heart transplantation, and post-transplant mortality and morbidity. METHODS: This was an observational single-centre retrospective study. Patients admitted to surg...

Descripción completa

Detalles Bibliográficos
Autores principales: Tohme, Joanna, Lescroart, Mickael, Guillemin, Jérémie, Orer, Pascal, Dureau, Pauline, Varnous, Shaida, Leprince, Pascal, Coutance, Guillaume, Bouglé, Adrien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118996/
https://www.ncbi.nlm.nih.gov/pubmed/37067499
http://dx.doi.org/10.1093/icvts/ivad055
_version_ 1785028926714675200
author Tohme, Joanna
Lescroart, Mickael
Guillemin, Jérémie
Orer, Pascal
Dureau, Pauline
Varnous, Shaida
Leprince, Pascal
Coutance, Guillaume
Bouglé, Adrien
author_facet Tohme, Joanna
Lescroart, Mickael
Guillemin, Jérémie
Orer, Pascal
Dureau, Pauline
Varnous, Shaida
Leprince, Pascal
Coutance, Guillaume
Bouglé, Adrien
author_sort Tohme, Joanna
collection PubMed
description OBJECTIVES: The aim of this study was to evaluate the association between vasoactive–inotropic score (VIS), calculated in the 24 h after heart transplantation, and post-transplant mortality and morbidity. METHODS: This was an observational single-centre retrospective study. Patients admitted to surgical intensive care unit after transplantation, between January 2015 and December 2018, were reviewed consecutively. VIS(max) was calculated as dopamine+ dobutamine+ 100 × epinephrine + 100 × norepinephrine + 50 × levosimendan + 10 × milrinone (all in µg/kg/min) + 10 000 × vasopressin (units/kg/min), using the maximum dosing rates of vasoactive and inotropic medications in the 24 h after intensive care unit admission. The primary outcome was mortality at 1 year post-transplant. The secondary outcomes included length of stay, duration of mechanical ventilation and inotropic support and the occurrence of septic shock, ventilator-associated pneumonia, bloodstream infection or renal replacement therapy. RESULTS: A total of 151 patients underwent heart transplantation and admitted to intensive care unit. The median VIS(max) was 39.2 (interquartile range = 19.4–83.0). VIS(max) was independently associated with 1-year post-transplant mortality, as well as recipient age [hazard ratio (HR) = 1.004, P-value = 0.013], recipient gender (female to male: hazard ratio = 2.23, P-value = 0.047) and combined transplantation (hazard ratio = 2.85, P-value = 0.048). There was a significant association between VIS(max) and duration of mechanical ventilation (P-value < 0.001), length of stay (P-value = 0.002), duration of infused inotropes (P-value < 0.001), occurrence of bloodstream infections, septic shocks, ventilation-acquired pneumonia and renal replacement therapy. CONCLUSIONS: VIS(max) calculated during the first 24 h after postoperative intensive care unit admission in transplanted patients is independently associated with 1-year mortality. In addition, length of stay, duration of mechanical ventilation and infused inotropes increased with increasing VIS(max).
format Online
Article
Text
id pubmed-10118996
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101189962023-04-22 Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation Tohme, Joanna Lescroart, Mickael Guillemin, Jérémie Orer, Pascal Dureau, Pauline Varnous, Shaida Leprince, Pascal Coutance, Guillaume Bouglé, Adrien Interdiscip Cardiovasc Thorac Surg Heart Failure OBJECTIVES: The aim of this study was to evaluate the association between vasoactive–inotropic score (VIS), calculated in the 24 h after heart transplantation, and post-transplant mortality and morbidity. METHODS: This was an observational single-centre retrospective study. Patients admitted to surgical intensive care unit after transplantation, between January 2015 and December 2018, were reviewed consecutively. VIS(max) was calculated as dopamine+ dobutamine+ 100 × epinephrine + 100 × norepinephrine + 50 × levosimendan + 10 × milrinone (all in µg/kg/min) + 10 000 × vasopressin (units/kg/min), using the maximum dosing rates of vasoactive and inotropic medications in the 24 h after intensive care unit admission. The primary outcome was mortality at 1 year post-transplant. The secondary outcomes included length of stay, duration of mechanical ventilation and inotropic support and the occurrence of septic shock, ventilator-associated pneumonia, bloodstream infection or renal replacement therapy. RESULTS: A total of 151 patients underwent heart transplantation and admitted to intensive care unit. The median VIS(max) was 39.2 (interquartile range = 19.4–83.0). VIS(max) was independently associated with 1-year post-transplant mortality, as well as recipient age [hazard ratio (HR) = 1.004, P-value = 0.013], recipient gender (female to male: hazard ratio = 2.23, P-value = 0.047) and combined transplantation (hazard ratio = 2.85, P-value = 0.048). There was a significant association between VIS(max) and duration of mechanical ventilation (P-value < 0.001), length of stay (P-value = 0.002), duration of infused inotropes (P-value < 0.001), occurrence of bloodstream infections, septic shocks, ventilation-acquired pneumonia and renal replacement therapy. CONCLUSIONS: VIS(max) calculated during the first 24 h after postoperative intensive care unit admission in transplanted patients is independently associated with 1-year mortality. In addition, length of stay, duration of mechanical ventilation and infused inotropes increased with increasing VIS(max). Oxford University Press 2023-04-17 /pmc/articles/PMC10118996/ /pubmed/37067499 http://dx.doi.org/10.1093/icvts/ivad055 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Heart Failure
Tohme, Joanna
Lescroart, Mickael
Guillemin, Jérémie
Orer, Pascal
Dureau, Pauline
Varnous, Shaida
Leprince, Pascal
Coutance, Guillaume
Bouglé, Adrien
Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
title Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
title_full Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
title_fullStr Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
title_full_unstemmed Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
title_short Association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
title_sort association between vasoactive–inotropic score, morbidity and mortality after heart transplantation
topic Heart Failure
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118996/
https://www.ncbi.nlm.nih.gov/pubmed/37067499
http://dx.doi.org/10.1093/icvts/ivad055
work_keys_str_mv AT tohmejoanna associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT lescroartmickael associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT guilleminjeremie associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT orerpascal associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT dureaupauline associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT varnousshaida associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT leprincepascal associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT coutanceguillaume associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation
AT bougleadrien associationbetweenvasoactiveinotropicscoremorbidityandmortalityafterhearttransplantation